IGF Level in Breast Cancer Patients Treated With Metformin

• Status: Completed
• Trial end date: 2021-07-31
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to examine the impact of metformin as an adjuvant to chemotherapy on IGF levels in both progressing and non progressing cases of metastatic breast cancer in female patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Beni-Suef University
• Treatments: Metformin

Criteria

Inclusion Criteria:

• Female patients with MBC

• patients older than 18

• nondiabetic patients

• patients who received only chemotherapy

Exclusion Criteria:

• patients with non-metastatic breast cancer

• patients receiving hormonal therapy or radiotherapy

• patients with diabetes

• history of cardiac diseases

• hypersensitivity, or allergy to metformin.